This study exists to understand whether the medication SPN-812 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication SPN-812 in practice and what may need to be adjusted.
This study exists to understand whether the medication SPN-812 is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication SPN-812 can improve attention, thinking, or day-to-day functioning.
This study exists to understand whether the medication SPN-812 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication SPN-812 in practice and what may need to be adjusted.
This study exists to understand whether the medication SPN-812 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication SPN-812 in practice and what may need to be adjusted.
This study is looking at evaluate the long-term outcomes among individuals participating in this clinical service for people with Prodromal Schizophrenia. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.